Share this post on:

Product Name: BIRC2 Antibody
Species Reactivity: Human
Tested Applications: IHC, WB
Applications: BIRC2 antibody can be used in immunohistochemistry starting at 10 μg/mL.
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight:
Immunogen: BIRC2 antibody was raised against a synthetic peptide corresponding to 361 – 372 of BIRC2 (Human).
Host Species: Rabbit
Purification: Antiserum
Physical State: Liquid
CAS NO.: 173553
Product: 6α-Methylprednisolone 21-hemisuccinate (sodium salt)
Buffer: Neat serum, 0.05% sodium azide.
Concentration:
Storage Conditions: BIRC2 antibody can be stored short term 4 ˚C. For long term storage aliquot and store at -20 ˚C. As with all antibodies avoid freeze/thaw cycles.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: BIRC2, API1, C-IAP1, CIAP1, Hiap-2, IAP homolog B, HIAP2, IAP-2, RNF48, Apoptosis inhibitor 1, IAP2, MIHB, RING finger protein 48
Accession NO.: Q13490
Protein Ino: 2497238
Official Symbol: BIRC2
Geneid: 329
Background: The inhibitor of apoptosis (IAP) family of proteins regulates programmed cell death triggered by various stimuli. All IAPs have at least one baculovirus IAP repeat (BIR) motif that is essential for their anti-apoptotic activity. c-IAP1 and c-IAP2, that are closely related mammalian members of the inhibitor of apoptosis protein (IAP) family originally identified in baculoviruses. Apoptosis, or programmed cell death, is related to many diseases, such as cancer. Apoptosis is triggered by a variety of stimuli including members in the TNF family and can be prevented by the inhibitor of apoptosis (IAP) proteins. IAP proteins form a conserved gene family that binds to and inhibits cell death proteases. The two isoforms of c-IAP (c-IAP1 and c-IAP2) are structurally related to XIAP, containing 3 baculoviral IAP repeat (BIR) motifs that are essential and sufficient for the binding and inhibition of caspases-3, -7. The c-IAPs can associate with the death receptor TNF-R2, and mediate the ubiquitinization of TRAF2 following the binding of TNF-a by its receptor. Omi, a negative regulator of c-IAP, inhibits its activity by catalytically cleaving c-IAP. Another negative regulator, Smac/DIABLO, acts by enhancing the auto-ubiquitization activity of c-IAP.
PubMed ID:http://aac.asm.org/content/42/3/495.abstract

Share this post on:

Author: Betaine hydrochloride